Skip to main content
JLK, Inc. logo

JLK, Inc. — Investor Relations & Filings

Ticker · 322510 ISIN · KR7322510009 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 303 across all filing types
Latest filing 2020-09-03 Regulatory Filings
Country KR South Korea
Listing KO 322510

About JLK, Inc.

https://www.jlkgroup.com/en/

JLK, Inc. is an artificial intelligence company that develops medical and data solutions. The company specializes in AI-driven technologies for the entire stroke treatment cycle, from diagnosis to prognosis. Its flagship platform, MEDIHUB STROKE, is a comprehensive solution that utilizes multi-modality medical imaging analysis (CT, MRI) to provide rapid and precise decision support for both ischemic and hemorrhagic strokes. Beyond its primary focus on stroke care, JLK's MEDIHUB platform also includes solutions for dementia and cancer. The company has also developed MEDIHUB TELE, an AI-powered telemedicine platform for remote consultations, and Hello Data, a data management platform optimized for AI machine learning that serves the medical sector and other industries, including autonomous driving and manufacturing.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) by JLK. It details the contract value, counterparty, and duration. Since this is a specific regulatory disclosure regarding a business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2020-09-03 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by the company JLK. It details the contract amount, the counterparty, the contract period, and the nature of the services provided. This type of disclosure is a standard regulatory filing in the Korean market (DART system) for material business contracts. Since it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2020-09-03 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal disclosure of a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) by JLK. It details the contract value, counterparty, and duration. Since this is a specific regulatory disclosure regarding a business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2020-09-03 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by JLK. It details the contract amount, counterparty, and duration. Since this is a specific regulatory disclosure regarding a business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2020-09-03 Korean
기타경영사항(특허권취득)(자율공시)(암 영역에 대한 딥러닝 모델 학습 장치 및 방법)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company JLK. It details the patent name, content, and application plan. Since this is a specific corporate announcement regarding business operations/intellectual property that does not fit into financial reporting, governance, or shareholder-specific categories, it falls under the general regulatory filing category.
2020-08-27 Korean
투자판단관련주요경영사항((인공지능 기반 의료 솔루션 터키 의료기기 품목허가 완료(총 7건)))
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean stock exchange (DART system) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details the approval of medical device licenses in Turkey for seven AI-based medical solutions. Since this is a specific regulatory announcement of a business development/operational milestone that does not fit into financial reporting, dividend, or governance categories, it is classified as a general regulatory filing.
2020-08-26 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.